FDA issues safety alert on breast implant-associated cancers
The Food and Drug Administration yesterday alerted health care providers and the public to reports of squamous cell carcinoma in scar tissue around breast implants, as well as lymphomas different than those previously associated with breast implants. The agency recommends that health care providers continue to report cancers around breast implants to help it identify and better understand this emerging issue.
Related News Articles
Headline
The Health Resources and Services Administration Maternal and Child Health Bureau has announced grant opportunities available supporting maternal and child…
Headline
Hospital and health system leaders gathered June 17 and 18 in Washington, D.C., for U.S. News & World Report’s Healthcare of Tomorrow Conference, focusing…
Headline
Sarah Stella, M.D., director of Denver Health’s Housing Outreach, Partnerships and Engagement program, or HOPE, reveals how Denver Health is helping some of…
Headline
The AHA is launching a new learning collaborative, Adopting Digital Tools for Better Aging Care, which is part of the West Health Accelerator at AHA’s Health…
Headline
The Centers for Disease Control and Prevention will host a webinar for clinicians May 28 at 2 p.m. ET on the ongoing Ebola outbreak in the Democratic…
Headline
The convening of 600 leaders from hospitals, health systems, and community and public health organizations continued for a full-day schedule at the AHA…